Virus News and Research

Latest Virus News and Research

How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?

Now, researchers from Public Health Services Israel have been investigating a new variant called Lambda to see if it qualifies as a variant of concern. Their research is published in the journal Eurosurveillance.

16 Nov 2021

New computer software can help track and analyze pandemics before they spread

Researchers at Georgia State University have created lightning-fast computer software that can help nations track and analyze pandemics, like the one caused by COVID-19, before they spread like wildfire around the globe.

16 Nov 2021

New atomic-level insight of SARS-CoV-2 within a respiratory aerosol

In a paradigm-shifting paper currently available on the bioRxiv* preprint server, the researchers have dramatically extended the possibilities of computational microscopy in order to better understand both structure and dynamics of respiratory aerosols laden with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

16 Nov 2021

Scientists identify new gene that contributes to type 1 diabetes progression

When the pro-inflammatory pair, a receptor called CCR2 and its ligand CCL-2, get together, it increases the risk of developing type 1 diabetes, scientists report.

16 Nov 2021

EuroEcho 2021 to highlight latest developments in cardiovascular imaging

Get ready for the latest developments in cardiovascular imaging - including gender differences and long COVID - at EuroEcho 2021, a scientific congress of the European Society of Cardiology (ESC).

16 Nov 2021

Air filtration device removes almost all traces of airborne SARS-CoV-2

When a team of doctors, scientists and engineers at Addenbrooke's Hospital and the University of Cambridge placed an air filtration machine in COVID-19 wards, they found that it removed almost all traces of airborne SARS-CoV-2.

16 Nov 2021

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination and are at significantly higher levels than for those who are unvaccinated.

16 Nov 2021

A therapeutic interfering particle for SARS-CoV-2

Researchers report their attempt to engineer TIPs that can conditionally replicate with SARS-CoV-2, inhibit viral replication 10–100 fold, and exhibit R0>1.

16 Nov 2021

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Researchers recently conducted a study to identify host factors affecting cellular interactions of the SARS-CoV-2 spike protein.

16 Nov 2021

SARS-CoV-2 replicates in human placenta with release of infectious viral particles

The current study analyzed the interaction of SARS-CoV-2 at the human maternal-fetal interface by using an advanced ex vivo model.

16 Nov 2021

More than 13 million people in the UK received COVID-19 booster jabs

More than 13 million life-saving booster jabs have been given across the UK, marking another significant milestone in the phenomenal COVID-19 vaccination programme.

16 Nov 2021

As big pharma and hospitals battle over drug discounts, patients miss out on millions in benefits

In early July, as the covid-19 pandemic slammed rural America, the president of a small Kansas hospital sat down on a Friday afternoon and wrote the president of the United States to plead for help.

16 Nov 2021

Impact of COVID-19 vaccination in the Norwegian population

Researchers quantified the general VE achieved in the population of Norway, with the realized mixture of vaccine types, current population characteristics, and epidemic trajectory and directly estimated VE across vaccine types and age groups.

16 Nov 2021

Identification of transcription regulatory sequences and genes in previously unannotated coronaviruses

Scientists have hypothesized that the presence of regulatory sequences could be effectively used to instantaneously and accurately identify TRS sites as well as the related viral genes in unannotated coronavirus genomes.

16 Nov 2021

Broad neutralization capability of potent nanobody against SARS-CoV-2 variants

A new study has described the molecular basis of the neutralization potency and breadth of nanobodies.

16 Nov 2021

Diagnostic sensitivity, viral load and infectivity of SARS-CoV-2 in paired respiratory and oral samples

To understand the viral load in different sections of infected individuals, their respective shedding patterns, and the sensitivity of the SARS-CoV-2 assays, researchers published a study.

16 Nov 2021

Myocarditis among Moderna COVID-19 vaccine recipients

A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.

16 Nov 2021

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

A new preprint reports a semi-quantitative test that can measure neutralizing antibodies to the SARS-CoV-2 pathogen at the point of care, using a finger stick or venipuncture blood.

16 Nov 2021

Deficient spike-specific T cell responses and inability to neutralize SARS-CoV-2 variants 12 month post-infection

Researchers conducted a comprehensive, longitudinal, long-term immune study, including functional assays to assess immune fitness against antigenically different VoC. The study is currently available on the preprint server medRxiv* while awaiting peer review.

15 Nov 2021

Study analyzes association between obesity and endothelial dysfunction in COVID-19 patients

In COVID-19 patients, obesity is the factor most associated with the development of endothelial dysfunction, a condition in which the blood vessels become unable to contract and relax adequately, increasing the risk of events such as heart attacks, thrombosis (blood clotting), and stroke.

15 Nov 2021

Virus News and Research

Latest Virus News and Research

How effective is the COMIRNATY BNT162b2 vaccine against the SARS-CoV-2 Lambda variant?

New computer software can help track and analyze pandemics before they spread

New atomic-level insight of SARS-CoV-2 within a respiratory aerosol

Scientists identify new gene that contributes to type 1 diabetes progression

EuroEcho 2021 to highlight latest developments in cardiovascular imaging

Air filtration device removes almost all traces of airborne SARS-CoV-2

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

A therapeutic interfering particle for SARS-CoV-2

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

SARS-CoV-2 replicates in human placenta with release of infectious viral particles

More than 13 million people in the UK received COVID-19 booster jabs

As big pharma and hospitals battle over drug discounts, patients miss out on millions in benefits

Impact of COVID-19 vaccination in the Norwegian population

Identification of transcription regulatory sequences and genes in previously unannotated coronaviruses

Broad neutralization capability of potent nanobody against SARS-CoV-2 variants

Diagnostic sensitivity, viral load and infectivity of SARS-CoV-2 in paired respiratory and oral samples

Myocarditis among Moderna COVID-19 vaccine recipients

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

Deficient spike-specific T cell responses and inability to neutralize SARS-CoV-2 variants 12 month post-infection

Study analyzes association between obesity and endothelial dysfunction in COVID-19 patients

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in